National Research (NASDAQ:NRC) Stock Price Passes Above 200 Day Moving Average of $37.09

National Research Co. (NASDAQ:NRCGet Rating) shares passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $37.09 and traded as high as $37.31. National Research shares last traded at $36.81, with a volume of 27,963 shares changing hands.

National Research Stock Performance

The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.20 and a current ratio of 1.20. The company has a market capitalization of $908.88 million, a price-to-earnings ratio of 26.67 and a beta of 0.50. The stock’s 50-day moving average price is $39.20 and its 200-day moving average price is $37.09.

National Research Cuts Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 13th. Shareholders of record on Friday, December 30th will be issued a $0.12 dividend. The ex-dividend date of this dividend is Thursday, December 29th. This represents a $0.48 dividend on an annualized basis and a yield of 1.30%. National Research’s dividend payout ratio is currently 69.57%.

Insiders Place Their Bets

In related news, major shareholder Amandla Mk Trust sold 14,872 shares of the company’s stock in a transaction that occurred on Friday, October 28th. The shares were sold at an average price of $40.98, for a total value of $609,454.56. Following the completion of the sale, the insider now owns 4,465,732 shares in the company, valued at approximately $183,005,697.36. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In the last 90 days, insiders sold 246,762 shares of company stock worth $9,822,462. Insiders own 2.00% of the company’s stock.

Institutional Investors Weigh In On National Research

Institutional investors have recently modified their holdings of the business. Envestnet Asset Management Inc. increased its holdings in shares of National Research by 7.9% in the first quarter. Envestnet Asset Management Inc. now owns 8,161 shares of the company’s stock valued at $324,000 after purchasing an additional 599 shares during the last quarter. Victory Capital Management Inc. grew its position in National Research by 9.3% in the 1st quarter. Victory Capital Management Inc. now owns 10,903 shares of the company’s stock valued at $374,000 after purchasing an additional 927 shares during the period. Touchstone Capital Inc. lifted its stake in National Research by 1.6% during the 1st quarter. Touchstone Capital Inc. now owns 279,841 shares of the company’s stock valued at $11,096,000 after acquiring an additional 4,424 shares in the last quarter. Qube Research & Technologies Ltd raised its stake in shares of National Research by 24.1% during the 1st quarter. Qube Research & Technologies Ltd now owns 11,041 shares of the company’s stock worth $438,000 after purchasing an additional 2,144 shares during the period. Finally, M&T Bank Corp purchased a new stake in National Research in the 1st quarter worth about $352,000. Institutional investors and hedge funds own 67.51% of the company’s stock.

National Research Company Profile

(Get Rating)

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty.

Further Reading

Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with's FREE daily email newsletter.